相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)
Alexander Egeberg et al.
BRITISH JOURNAL OF DERMATOLOGY (2023)
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System
Maria Antonietta Barbieri et al.
CANCERS (2023)
Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Lindsay N. Moreland-Head et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2021)
Pharmacovigilance-based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections
Ruwen Boehm et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Multikinase Inhibitor Treatment in Thyroid Cancer
Ole Vincent Ancker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Renal adverse effects following the use of different immune checkpoint inhibitor regimens: A real-world pharmacoepidemiology study of post-marketing surveillance data
Gang Chen et al.
CANCER MEDICINE (2020)
Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer
Mimi I. Hu et al.
ENDOCRINE-RELATED CANCER (2019)
Risk of fatal adverse events in cancer patients treated with sunitinib
Bin Zhao et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Prolonged duration of response in lenvatinib responders with thyroid cancer
Andrew G. Gianoukakis et al.
ENDOCRINE-RELATED CANCER (2018)
Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study
Mijin Kim et al.
THYROID (2018)
Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program
Catharina Balmelli et al.
JOURNAL OF CANCER (2018)
Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System
Jae Min et al.
DRUG SAFETY (2018)
The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors
Ole Vincent Ancker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis
V. R. Belum et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2016)
Insights into brain metastasis in patients with ALK plus lung cancer: is the brain truly a sanctuary?
Gouji Toyokawa et al.
CANCER AND METASTASIS REVIEWS (2015)
CSF Concentration of Crizotinib in Two ALK-Positive Non-Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment
Giulio Metro et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Psychotic disorder induced by a combination of sorafenib and BAY86-9766
Yen Lin Kuo et al.
GENERAL HOSPITAL PSYCHIATRY (2014)
Sunitinib-induced Acute Psychosis: Case Report
Victoria Kunene et al.
CLINICAL GENITOURINARY CANCER (2011)
Experience with sorafenib and adverse event management
Joaquim Bellmunt et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Extracellular Signal-Regulated Kinase Signaling in the Ventral Tegmental Area Mediates Cocaine-Induced Synaptic Plasticity and Rewarding Effects
Bin Pan et al.
JOURNAL OF NEUROSCIENCE (2011)
The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain
Sagar Agarwal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
ERK in Learning and Memory: A Review of Recent Research
Sheng Peng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma
Erkan Dogan et al.
MEDICAL ONCOLOGY (2010)
Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
H. Rezaei Kalantari
BRITISH JOURNAL OF CANCER (2009)
Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma Clinical article
Kenneth L. Hill et al.
JOURNAL OF NEUROSURGERY (2009)
Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects
Sadanand Fulzele et al.
SCHIZOPHRENIA RESEARCH (2009)
Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol
Jesus Bertran-Gonzalez et al.
JOURNAL OF NEUROSCIENCE (2008)
The effects of repeated administrations of MK-801 on ERK and GSK-3β signalling pathways in the rat frontal cortex
Myoung Suk Seo et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Mechanisms of hypertension associated with BAY 43-9006
ML Veronese et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mitogen-activated protein kinase/extracellular regulated kinase signalling and memory stabilization: a review
S Davis et al.
GENES BRAIN AND BEHAVIOR (2006)
Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase
ZG Jin et al.
CIRCULATION RESEARCH (2003)
分享论文
